A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients
Continue reading »
Getting Quality Autism Therapy From Thousands of Miles Away
TUESDAY, Feb. 25, 2020 — By the time he was 7 months old, John Michael Crawford had been diagnosed with
Continue reading »Novel approach to immune system could lead to personalized therapy against sepsis
The human immune system uses two pre-programmed strategies to tackle infection. One is fever, a resistance mechanism that tries to
Continue reading »Triple-drug therapy TRIPLES survival rate of advanced breast cancer
Patients with terminal breast cancer could live for up to FIVE MONTHS longer by taking a cocktail of three drugs,
Continue reading »First investigational drug therapy for liver disease NASH awaiting FDA approval
Patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease and a leading cause for liver transplantation in the U.S., currently
Continue reading »Safety evaluation of conditionally immortalized cells for renal replacement therapy
A research team assessed the safety of conditionally immortalized proximal tubule epithelial cells for bioartificial kidney application, by using in
Continue reading »New combination therapy offers bowel cancer patients extra treatment option
Based on scientific findings of the Netherlands Cancer Institute, a new combination treatment has been developed for patients with metastatic
Continue reading »Animal-assisted therapy aids in spinal cord injury recovery
Every year, approximately 17,000 new cases of spinal cord injury are reported in the United States. Recovering from an SCI
Continue reading »Taking therapy off the couch and into the paddock
I am watching 15-year-old Seamus* step into a small arena and come face to face with a powerful chestnut stallion
Continue reading »Nivolumab combined with ipilimumab safe as first-line therapy for lung cancer patients
Combining the PD-1 immune check point inhibitor nivolumab with the monoclonal antibody ipilimumab showed a consistent safety profile in special
Continue reading »